VeriSIM Life Company
VeriSIM Life is a computational bioplatform that predicts the clinical outcomes of new drugs before clinical trials.
Investors
Founded Date:
2017-01-01
Total Funding:
21655908.0
Investor Type:
For Profit
Employee Number:
11-50
Funding Status:
Early Stage Venture
Technology:
Artificial Intelligence, Health Care, Machine Learning, SaaS
Last Funding Type:
Series A
Investors Number:
15.0
Last Funding Date:
2022-01-13
Industry:
Early Drug Development
Headquarters:
San Francisco, California, United States
Estimated Revenue:
$1M to $10M